Ultima-Semaglutide (EU) Ultima Pharmaceuticals

£126.00

Semaglutide is a GLP-1 receptor agonist peptide developed for metabolic disorder research. This pharmaceutical-grade compound from Ultima Pharmaceuticals enables laboratory investigation of incretin pathways and glucose homeostasis mechanisms.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Ultima-Semaglutide (EU) Ultima Pharmaceuticals
Ultima-Semaglutide (EU) Ultima Pharmaceuticals
£126.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Metabolic Research Overview

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist peptide widely studied for its effects on glucose homeostasis and metabolic regulation. This synthetic analogue shares 94% sequence identity with native human GLP-1 but incorporates amino acid modifications that significantly extend its half-life in biological systems. Researchers from Stroid UK Shop investigate semaglutide’s mechanisms within incretin pathways, examining its binding affinity to GLP-1 receptors and subsequent downstream signalling cascades that influence insulin secretion, glucagon suppression, and gastric motility.

Laboratory Applications

In preclinical models, semaglutide demonstrates potent effects on pancreatic beta-cell function and glucose-dependent insulin release. Research teams studying metabolic compounds examine this peptide’s ability to activate adenylyl cyclase and increase cyclic adenosine monophosphate (cAMP) levels in target tissues. The compound’s prolonged pharmacokinetic profile makes it valuable for studying sustained GLP-1 receptor activation in metabolic research protocols. Scientists also investigate semaglutide’s effects on hypothalamic appetite regulation centres and its interaction with neural pathways controlling food intake. Contemporary research extends to examining this peptide alongside other investigational compounds from selective androgen receptor modulators and peptide research collections to understand complex metabolic interactions.

Technical Specifications

Semaglutide Research Parameters
Molecular Formula C₁₇₁H₂₆₅N₄₃O₅₁
Molecular Weight 4113.58 g/mol
CAS Number 910463-68-2
Purity Grade Research grade
Storage Conditions 2-8°C refrigerated
Stability Verify with supplier documentation
Solubility Water soluble
Appearance White lyophilised powder

Research Compliance

This semaglutide preparation is manufactured by Ultima Pharmaceuticals exclusively for in-vitro laboratory research and analytical applications. This product is not intended for human consumption, veterinary use, or any therapeutic applications. Researchers must ensure compliance with institutional guidelines and local regulations governing peptide research compounds. Proper laboratory safety protocols, including appropriate personal protective equipment and controlled storage conditions, are essential when handling this research material.

Related